Schaffen Pharma SRL
1.0 FTESchaffen Pharma reported total assets of 246,323 € at the end of the 2025 financial year (annual accounts filed with the NBB on 20 Aug 2026), with 1 full-time equivalent.
The score of Schaffen Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -36 % Total assets +9 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Schaffen Pharma's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | −38,596 € | ||||
| Equity | 123,404 € | ||||
| Cash | 55,538 € | ||||
| EBITDA | −30,342 € | ||||
| Total assets | 246,323 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 20 Aug 2026
- Year ended 31 Dec 2024filed on 11 Sep 2025
- Year ended 31 Dec 2023filed on 08 Oct 2024
- Year ended 31 Dec 2022filed on 31 Aug 2023
- Year ended 31 Dec 2021filed on 20 Jul 2022
Schaffen Pharma's financial analysis
- Solvency50.1%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Schaffen Pharma
Schaffen Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0846.585.118
- VAT number
- BE0846585118
- Peppol
- Registered · 0208:0846585118 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 08 Jun 2012
- Registered office
- 3290 Diest
- Size
- Micro · 1.0 FTE
- Latest accounts
- 2025 · filed on 20 Aug 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Schaffen Pharma (SRL) has been based in Diest since 2012, active in: retail sale of pharmaceutical products. For 2025, it reports a net loss of 38,596 € and equity of 123,404 €; its revenue is not published. With 1.0 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 50.1%, above the median of its sector (44.2%).
Companies similar to Schaffen Pharma
Companies in the same business, of comparable size and area, outside its group.
- Apoteek Bellekens Retail sale of pharmaceutical products Antwerp · balance sheet 247,504 €
- Pharma Daive Retail sale of pharmaceutical products Péruwelz · balance sheet 247,671 €
- Pharmacie Lenain Retail sale of pharmaceutical products Châtelet · balance sheet 244,877 €
- Lolophar Retail sale of pharmaceutical products Ghent · balance sheet 248,113 €
- Apotheek Velghe Ronse Retail sale of pharmaceutical products Maarkedal · balance sheet 244,455 €
- Fasylpharma Retail sale of pharmaceutical products Aiseau-Presles · balance sheet 250,318 €
- Sapos Retail sale of pharmaceutical products Aalst · balance sheet 241,792 €
- Odepharma Retail sale of pharmaceutical products Koksijde · balance sheet 255,295 €
Frequently asked questions about Schaffen Pharma
What is the revenue of Schaffen Pharma?
Schaffen Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Schaffen Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0846585118 for Schaffen Pharma, if the company is VAT-registered. Its company number (CBE) is 0846.585.118.
Where is the registered office of Schaffen Pharma?
According to the CBE register, the registered office of Schaffen Pharma is in 3290 Diest.
What is the equity of Schaffen Pharma?
At the close of the 2025 financial year, the equity of Schaffen Pharma amounts to 123,404 €, a solvency of 50.1% of total assets.
How many people work at Schaffen Pharma?
1.0 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Schaffen Pharma?
The register lists 2 active mandates at Schaffen Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Schaffen Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →